nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP3A5—Paclitaxel—ovarian cancer	0.0826	0.189	CbGbCtD
Modafinil—CYP3A4—Topotecan—ovarian cancer	0.0651	0.149	CbGbCtD
Modafinil—CYP3A5—Docetaxel—ovarian cancer	0.0597	0.136	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—ovarian cancer	0.0565	0.129	CbGbCtD
Modafinil—CYP2C9—Paclitaxel—ovarian cancer	0.0554	0.126	CbGbCtD
Modafinil—CYP3A4—Vinorelbine—ovarian cancer	0.0458	0.105	CbGbCtD
Modafinil—CYP3A4—Paclitaxel—ovarian cancer	0.0322	0.0735	CbGbCtD
Modafinil—CYP3A4—Docetaxel—ovarian cancer	0.0233	0.0532	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—ovarian cancer	0.0174	0.0396	CbGbCtD
Modafinil—Paraesthesia—Paclitaxel—ovarian cancer	0.000426	0.000812	CcSEcCtD
Modafinil—Hypertension—Docetaxel—ovarian cancer	0.000425	0.000811	CcSEcCtD
Modafinil—Drowsiness—Epirubicin—ovarian cancer	0.000425	0.00081	CcSEcCtD
Modafinil—Bronchitis—Doxorubicin—ovarian cancer	0.000424	0.000809	CcSEcCtD
Modafinil—Dyspnoea—Paclitaxel—ovarian cancer	0.000423	0.000806	CcSEcCtD
Modafinil—Somnolence—Paclitaxel—ovarian cancer	0.000422	0.000804	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000422	0.000803	CcSEcCtD
Modafinil—Chest pain—Docetaxel—ovarian cancer	0.000419	0.000799	CcSEcCtD
Modafinil—Arthralgia—Docetaxel—ovarian cancer	0.000419	0.000799	CcSEcCtD
Modafinil—Myalgia—Docetaxel—ovarian cancer	0.000419	0.000799	CcSEcCtD
Modafinil—Pancytopenia—Doxorubicin—ovarian cancer	0.000419	0.000799	CcSEcCtD
Modafinil—Nausea—Vinorelbine—ovarian cancer	0.000419	0.000798	CcSEcCtD
Modafinil—Dyspepsia—Paclitaxel—ovarian cancer	0.000417	0.000796	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000416	0.000794	CcSEcCtD
Modafinil—Stomatitis—Epirubicin—ovarian cancer	0.000414	0.00079	CcSEcCtD
Modafinil—Urinary tract infection—Epirubicin—ovarian cancer	0.000413	0.000788	CcSEcCtD
Modafinil—Conjunctivitis—Epirubicin—ovarian cancer	0.000413	0.000788	CcSEcCtD
Modafinil—Decreased appetite—Paclitaxel—ovarian cancer	0.000412	0.000786	CcSEcCtD
Modafinil—Dry mouth—Docetaxel—ovarian cancer	0.00041	0.000782	CcSEcCtD
Modafinil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000409	0.000781	CcSEcCtD
Modafinil—Fatigue—Paclitaxel—ovarian cancer	0.000409	0.000779	CcSEcCtD
Modafinil—Sweating—Epirubicin—ovarian cancer	0.000408	0.000777	CcSEcCtD
Modafinil—Pollakiuria—Doxorubicin—ovarian cancer	0.000408	0.000777	CcSEcCtD
Modafinil—Pain—Paclitaxel—ovarian cancer	0.000406	0.000773	CcSEcCtD
Modafinil—Constipation—Paclitaxel—ovarian cancer	0.000406	0.000773	CcSEcCtD
Modafinil—Haematuria—Epirubicin—ovarian cancer	0.000405	0.000773	CcSEcCtD
Modafinil—Confusional state—Docetaxel—ovarian cancer	0.000405	0.000773	CcSEcCtD
Modafinil—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000403	0.000768	CcSEcCtD
Modafinil—Anaphylactic shock—Docetaxel—ovarian cancer	0.000402	0.000766	CcSEcCtD
Modafinil—Oedema—Docetaxel—ovarian cancer	0.000402	0.000766	CcSEcCtD
Modafinil—Weight increased—Doxorubicin—ovarian cancer	0.000402	0.000765	CcSEcCtD
Modafinil—Epistaxis—Epirubicin—ovarian cancer	0.000401	0.000764	CcSEcCtD
Modafinil—Infection—Docetaxel—ovarian cancer	0.000399	0.000761	CcSEcCtD
Modafinil—Weight decreased—Doxorubicin—ovarian cancer	0.000399	0.000761	CcSEcCtD
Modafinil—Sinusitis—Epirubicin—ovarian cancer	0.000399	0.00076	CcSEcCtD
Modafinil—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000398	0.000759	CcSEcCtD
Modafinil—Agranulocytosis—Epirubicin—ovarian cancer	0.000397	0.000756	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—ovarian cancer	0.000396	0.000754	CcSEcCtD
Modafinil—Shock—Docetaxel—ovarian cancer	0.000396	0.000754	CcSEcCtD
Modafinil—Nervous system disorder—Docetaxel—ovarian cancer	0.000394	0.000752	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—ovarian cancer	0.000393	0.00075	CcSEcCtD
Modafinil—Tachycardia—Docetaxel—ovarian cancer	0.000392	0.000748	CcSEcCtD
Modafinil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000391	0.000745	CcSEcCtD
Modafinil—Skin disorder—Docetaxel—ovarian cancer	0.00039	0.000744	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00039	0.000743	CcSEcCtD
Modafinil—Bradycardia—Epirubicin—ovarian cancer	0.000389	0.000741	CcSEcCtD
Modafinil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000388	0.000739	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—ovarian cancer	0.000383	0.000731	CcSEcCtD
Modafinil—Anorexia—Docetaxel—ovarian cancer	0.000383	0.00073	CcSEcCtD
Modafinil—Rhinitis—Epirubicin—ovarian cancer	0.000383	0.000729	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—ovarian cancer	0.000382	0.000729	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—ovarian cancer	0.000382	0.000729	CcSEcCtD
Modafinil—Pharyngitis—Epirubicin—ovarian cancer	0.000379	0.000722	CcSEcCtD
Modafinil—Sweating—Doxorubicin—ovarian cancer	0.000377	0.000719	CcSEcCtD
Modafinil—Urinary tract disorder—Epirubicin—ovarian cancer	0.000377	0.000718	CcSEcCtD
Modafinil—Urticaria—Paclitaxel—ovarian cancer	0.000377	0.000718	CcSEcCtD
Modafinil—Oedema peripheral—Epirubicin—ovarian cancer	0.000376	0.000717	CcSEcCtD
Modafinil—Hypotension—Docetaxel—ovarian cancer	0.000376	0.000716	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—ovarian cancer	0.000375	0.000715	CcSEcCtD
Modafinil—Connective tissue disorder—Epirubicin—ovarian cancer	0.000375	0.000715	CcSEcCtD
Modafinil—Abdominal pain—Paclitaxel—ovarian cancer	0.000375	0.000715	CcSEcCtD
Modafinil—Body temperature increased—Paclitaxel—ovarian cancer	0.000375	0.000715	CcSEcCtD
Modafinil—Urethral disorder—Epirubicin—ovarian cancer	0.000374	0.000713	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—ovarian cancer	0.000371	0.000707	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—ovarian cancer	0.000369	0.000704	CcSEcCtD
Modafinil—Visual impairment—Epirubicin—ovarian cancer	0.000368	0.000701	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—ovarian cancer	0.000367	0.0007	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000366	0.000698	CcSEcCtD
Modafinil—Insomnia—Docetaxel—ovarian cancer	0.000364	0.000693	CcSEcCtD
Modafinil—Paraesthesia—Docetaxel—ovarian cancer	0.000361	0.000688	CcSEcCtD
Modafinil—Erythema multiforme—Epirubicin—ovarian cancer	0.000361	0.000688	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—ovarian cancer	0.00036	0.000685	CcSEcCtD
Modafinil—Dyspnoea—Docetaxel—ovarian cancer	0.000358	0.000683	CcSEcCtD
Modafinil—Somnolence—Docetaxel—ovarian cancer	0.000357	0.000681	CcSEcCtD
Modafinil—Cardiac disorder—Epirubicin—ovarian cancer	0.000354	0.000675	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—ovarian cancer	0.000354	0.000675	CcSEcCtD
Modafinil—Dyspepsia—Docetaxel—ovarian cancer	0.000354	0.000675	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—ovarian cancer	0.00035	0.000668	CcSEcCtD
Modafinil—Decreased appetite—Docetaxel—ovarian cancer	0.000349	0.000666	CcSEcCtD
Modafinil—Hypersensitivity—Paclitaxel—ovarian cancer	0.000349	0.000666	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000349	0.000665	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—ovarian cancer	0.000348	0.000663	CcSEcCtD
Modafinil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000347	0.000662	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000347	0.000662	CcSEcCtD
Modafinil—Fatigue—Docetaxel—ovarian cancer	0.000347	0.000661	CcSEcCtD
Modafinil—Angiopathy—Epirubicin—ovarian cancer	0.000346	0.00066	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—ovarian cancer	0.000346	0.00066	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—ovarian cancer	0.000345	0.000657	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—ovarian cancer	0.000344	0.000656	CcSEcCtD
Modafinil—Pain—Docetaxel—ovarian cancer	0.000344	0.000655	CcSEcCtD
Modafinil—Constipation—Docetaxel—ovarian cancer	0.000344	0.000655	CcSEcCtD
Modafinil—Chills—Epirubicin—ovarian cancer	0.000342	0.000653	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—ovarian cancer	0.000341	0.00065	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—ovarian cancer	0.00034	0.000649	CcSEcCtD
Modafinil—Asthenia—Paclitaxel—ovarian cancer	0.00034	0.000649	CcSEcCtD
Modafinil—Pruritus—Paclitaxel—ovarian cancer	0.000336	0.00064	CcSEcCtD
Modafinil—Mental disorder—Epirubicin—ovarian cancer	0.000334	0.000637	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—ovarian cancer	0.000334	0.000636	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—ovarian cancer	0.000332	0.000633	CcSEcCtD
Modafinil—Feeling abnormal—Docetaxel—ovarian cancer	0.000331	0.000632	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000329	0.000627	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—ovarian cancer	0.000328	0.000625	CcSEcCtD
Modafinil—Flatulence—Epirubicin—ovarian cancer	0.000327	0.000624	CcSEcCtD
Modafinil—Tension—Epirubicin—ovarian cancer	0.000326	0.000621	CcSEcCtD
Modafinil—Dysgeusia—Epirubicin—ovarian cancer	0.000325	0.00062	CcSEcCtD
Modafinil—Diarrhoea—Paclitaxel—ovarian cancer	0.000325	0.000619	CcSEcCtD
Modafinil—Nervousness—Epirubicin—ovarian cancer	0.000323	0.000615	CcSEcCtD
Modafinil—Back pain—Epirubicin—ovarian cancer	0.000321	0.000613	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—ovarian cancer	0.00032	0.000611	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—ovarian cancer	0.000319	0.000609	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—ovarian cancer	0.000319	0.000608	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000318	0.000607	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—ovarian cancer	0.000318	0.000606	CcSEcCtD
Modafinil—Abdominal pain—Docetaxel—ovarian cancer	0.000318	0.000606	CcSEcCtD
Modafinil—Chills—Doxorubicin—ovarian cancer	0.000317	0.000604	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—ovarian cancer	0.000315	0.000601	CcSEcCtD
Modafinil—Dizziness—Paclitaxel—ovarian cancer	0.000314	0.000598	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—ovarian cancer	0.000309	0.00059	CcSEcCtD
Modafinil—Ill-defined disorder—Epirubicin—ovarian cancer	0.000308	0.000588	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—ovarian cancer	0.000307	0.000586	CcSEcCtD
Modafinil—Anaemia—Epirubicin—ovarian cancer	0.000307	0.000585	CcSEcCtD
Modafinil—Agitation—Epirubicin—ovarian cancer	0.000305	0.000582	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—ovarian cancer	0.000303	0.000577	CcSEcCtD
Modafinil—Tension—Doxorubicin—ovarian cancer	0.000302	0.000575	CcSEcCtD
Modafinil—Vomiting—Paclitaxel—ovarian cancer	0.000302	0.000575	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—ovarian cancer	0.000301	0.000574	CcSEcCtD
Modafinil—Malaise—Epirubicin—ovarian cancer	0.0003	0.000571	CcSEcCtD
Modafinil—Rash—Paclitaxel—ovarian cancer	0.000299	0.00057	CcSEcCtD
Modafinil—Dermatitis—Paclitaxel—ovarian cancer	0.000299	0.00057	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—ovarian cancer	0.000299	0.000569	CcSEcCtD
Modafinil—Vertigo—Epirubicin—ovarian cancer	0.000299	0.000569	CcSEcCtD
Modafinil—Syncope—Epirubicin—ovarian cancer	0.000298	0.000568	CcSEcCtD
Modafinil—Back pain—Doxorubicin—ovarian cancer	0.000297	0.000567	CcSEcCtD
Modafinil—Headache—Paclitaxel—ovarian cancer	0.000297	0.000566	CcSEcCtD
Modafinil—Ketoprofen—CXCL8—ovarian cancer	0.000297	0.524	CrCbGaD
Modafinil—Hypersensitivity—Docetaxel—ovarian cancer	0.000296	0.000565	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—ovarian cancer	0.000296	0.000563	CcSEcCtD
Modafinil—Palpitations—Epirubicin—ovarian cancer	0.000294	0.00056	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—ovarian cancer	0.000292	0.000557	CcSEcCtD
Modafinil—Cough—Epirubicin—ovarian cancer	0.00029	0.000553	CcSEcCtD
Modafinil—Asthenia—Docetaxel—ovarian cancer	0.000288	0.00055	CcSEcCtD
Modafinil—Convulsion—Epirubicin—ovarian cancer	0.000288	0.000549	CcSEcCtD
Modafinil—Hypertension—Epirubicin—ovarian cancer	0.000287	0.000547	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000285	0.000544	CcSEcCtD
Modafinil—Pruritus—Docetaxel—ovarian cancer	0.000284	0.000542	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—ovarian cancer	0.000284	0.000542	CcSEcCtD
Modafinil—Myalgia—Epirubicin—ovarian cancer	0.000283	0.000539	CcSEcCtD
Modafinil—Chest pain—Epirubicin—ovarian cancer	0.000283	0.000539	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—ovarian cancer	0.000283	0.000539	CcSEcCtD
Modafinil—Agitation—Doxorubicin—ovarian cancer	0.000283	0.000539	CcSEcCtD
Modafinil—Anxiety—Epirubicin—ovarian cancer	0.000282	0.000537	CcSEcCtD
Modafinil—Nausea—Paclitaxel—ovarian cancer	0.000282	0.000537	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000281	0.000535	CcSEcCtD
Modafinil—Discomfort—Epirubicin—ovarian cancer	0.000279	0.000533	CcSEcCtD
Modafinil—Malaise—Doxorubicin—ovarian cancer	0.000277	0.000528	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—ovarian cancer	0.000277	0.000527	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—ovarian cancer	0.000276	0.000526	CcSEcCtD
Modafinil—Syncope—Doxorubicin—ovarian cancer	0.000276	0.000526	CcSEcCtD
Modafinil—Diarrhoea—Docetaxel—ovarian cancer	0.000275	0.000524	CcSEcCtD
Modafinil—Confusional state—Epirubicin—ovarian cancer	0.000273	0.000521	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—ovarian cancer	0.000272	0.000518	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—ovarian cancer	0.000271	0.000517	CcSEcCtD
Modafinil—Oedema—Epirubicin—ovarian cancer	0.000271	0.000517	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—ovarian cancer	0.00027	0.000515	CcSEcCtD
Modafinil—Infection—Epirubicin—ovarian cancer	0.000269	0.000514	CcSEcCtD
Modafinil—Cough—Doxorubicin—ovarian cancer	0.000268	0.000511	CcSEcCtD
Modafinil—Shock—Epirubicin—ovarian cancer	0.000267	0.000509	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—ovarian cancer	0.000266	0.000508	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—ovarian cancer	0.000266	0.000507	CcSEcCtD
Modafinil—Dizziness—Docetaxel—ovarian cancer	0.000266	0.000507	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—ovarian cancer	0.000265	0.000506	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—ovarian cancer	0.000265	0.000504	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—ovarian cancer	0.000263	0.000502	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—ovarian cancer	0.000262	0.0005	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—ovarian cancer	0.000262	0.000499	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—ovarian cancer	0.000262	0.000499	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—ovarian cancer	0.000262	0.000499	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—ovarian cancer	0.000261	0.000497	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00026	0.000495	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—ovarian cancer	0.000259	0.000493	CcSEcCtD
Modafinil—Anorexia—Epirubicin—ovarian cancer	0.000258	0.000493	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—ovarian cancer	0.000256	0.000488	CcSEcCtD
Modafinil—Vomiting—Docetaxel—ovarian cancer	0.000256	0.000487	CcSEcCtD
Modafinil—Rash—Docetaxel—ovarian cancer	0.000253	0.000483	CcSEcCtD
Modafinil—Hypotension—Epirubicin—ovarian cancer	0.000253	0.000483	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—ovarian cancer	0.000253	0.000483	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—ovarian cancer	0.000253	0.000482	CcSEcCtD
Modafinil—Headache—Docetaxel—ovarian cancer	0.000252	0.00048	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000251	0.000478	CcSEcCtD
Modafinil—Oedema—Doxorubicin—ovarian cancer	0.000251	0.000478	CcSEcCtD
Modafinil—Infection—Doxorubicin—ovarian cancer	0.000249	0.000475	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000247	0.000471	CcSEcCtD
Modafinil—Shock—Doxorubicin—ovarian cancer	0.000247	0.000471	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000246	0.000469	CcSEcCtD
Modafinil—Insomnia—Epirubicin—ovarian cancer	0.000245	0.000468	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—ovarian cancer	0.000245	0.000467	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—ovarian cancer	0.000244	0.000465	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—ovarian cancer	0.000243	0.000464	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000243	0.000462	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—ovarian cancer	0.000242	0.000461	CcSEcCtD
Modafinil—Somnolence—Epirubicin—ovarian cancer	0.000241	0.00046	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—ovarian cancer	0.000239	0.000456	CcSEcCtD
Modafinil—Nausea—Docetaxel—ovarian cancer	0.000239	0.000455	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—ovarian cancer	0.000239	0.000455	CcSEcCtD
Modafinil—Decreased appetite—Epirubicin—ovarian cancer	0.000236	0.000449	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—ovarian cancer	0.000234	0.000447	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000234	0.000446	CcSEcCtD
Modafinil—Fatigue—Epirubicin—ovarian cancer	0.000234	0.000446	CcSEcCtD
Modafinil—Pain—Epirubicin—ovarian cancer	0.000232	0.000442	CcSEcCtD
Modafinil—Constipation—Epirubicin—ovarian cancer	0.000232	0.000442	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000229	0.000436	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—ovarian cancer	0.000227	0.000433	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—ovarian cancer	0.000225	0.000429	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—ovarian cancer	0.000224	0.000426	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—ovarian cancer	0.000223	0.000426	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—ovarian cancer	0.000223	0.000425	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000222	0.000423	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—ovarian cancer	0.000221	0.000421	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—ovarian cancer	0.000218	0.000416	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000217	0.000413	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—ovarian cancer	0.000216	0.000412	CcSEcCtD
Modafinil—Urticaria—Epirubicin—ovarian cancer	0.000215	0.000411	CcSEcCtD
Modafinil—Pain—Doxorubicin—ovarian cancer	0.000215	0.000409	CcSEcCtD
Modafinil—Constipation—Doxorubicin—ovarian cancer	0.000215	0.000409	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—ovarian cancer	0.000214	0.000409	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—ovarian cancer	0.000214	0.000409	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—ovarian cancer	0.000207	0.000394	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000205	0.000391	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—ovarian cancer	0.0002	0.000381	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—ovarian cancer	0.000199	0.00038	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—ovarian cancer	0.000198	0.000378	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—ovarian cancer	0.000198	0.000378	CcSEcCtD
Modafinil—Asthenia—Epirubicin—ovarian cancer	0.000195	0.000371	CcSEcCtD
Modafinil—Pruritus—Epirubicin—ovarian cancer	0.000192	0.000366	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—ovarian cancer	0.000186	0.000354	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—ovarian cancer	0.000185	0.000352	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—ovarian cancer	0.00018	0.000343	CcSEcCtD
Modafinil—Dizziness—Epirubicin—ovarian cancer	0.000179	0.000342	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—ovarian cancer	0.000178	0.000338	CcSEcCtD
Modafinil—Vomiting—Epirubicin—ovarian cancer	0.000172	0.000329	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—ovarian cancer	0.000172	0.000327	CcSEcCtD
Modafinil—Rash—Epirubicin—ovarian cancer	0.000171	0.000326	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—ovarian cancer	0.000171	0.000326	CcSEcCtD
Modafinil—Headache—Epirubicin—ovarian cancer	0.00017	0.000324	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—ovarian cancer	0.000166	0.000316	CcSEcCtD
Modafinil—Nausea—Epirubicin—ovarian cancer	0.000161	0.000307	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—ovarian cancer	0.00016	0.000304	CcSEcCtD
Modafinil—Rash—Doxorubicin—ovarian cancer	0.000158	0.000302	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—ovarian cancer	0.000158	0.000301	CcSEcCtD
Modafinil—Headache—Doxorubicin—ovarian cancer	0.000157	0.0003	CcSEcCtD
Modafinil—Nausea—Doxorubicin—ovarian cancer	0.000149	0.000284	CcSEcCtD
Modafinil—Fentanyl—ABCB1—ovarian cancer	7.64e-05	0.135	CrCbGaD
Modafinil—Carbamazepine—ABCB1—ovarian cancer	7.13e-05	0.126	CrCbGaD
Modafinil—Phenytoin—ABCB1—ovarian cancer	6.93e-05	0.122	CrCbGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	6.91e-05	0.00188	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HSD17B6—ovarian cancer	6.9e-05	0.00187	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—TP53—ovarian cancer	6.89e-05	0.00187	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	6.77e-05	0.00184	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (12/13) signalling events—PIK3CA—ovarian cancer	6.67e-05	0.00181	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	6.6e-05	0.00179	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	6.51e-05	0.00177	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	6.4e-05	0.00174	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—AKT1—ovarian cancer	6.18e-05	0.00168	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DLC1—ovarian cancer	5.87e-05	0.00159	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NME2—ovarian cancer	5.84e-05	0.00158	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—AKT1—ovarian cancer	5.82e-05	0.00158	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	5.75e-05	0.00156	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NME2—ovarian cancer	5.71e-05	0.00155	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	5.68e-05	0.00154	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	5.64e-05	0.00153	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.6e-05	0.00152	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.58e-05	0.00151	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	5.56e-05	0.00151	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.41e-05	0.00147	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	5.29e-05	0.00144	CbGpPWpGaD
Modafinil—Methadone—ABCB1—ovarian cancer	5.24e-05	0.0926	CrCbGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	5.18e-05	0.0014	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	5.17e-05	0.0014	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	5.17e-05	0.0014	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.09e-05	0.00138	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	4.89e-05	0.00133	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BCL9—ovarian cancer	4.78e-05	0.0013	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NME2—ovarian cancer	4.41e-05	0.0012	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.35e-05	0.00118	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.35e-05	0.00118	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.29e-05	0.00116	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.27e-05	0.00116	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	4.15e-05	0.00113	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.02e-05	0.00109	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NME2—ovarian cancer	4.02e-05	0.00109	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DOK1—ovarian cancer	3.78e-05	0.00103	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYTB—ovarian cancer	3.76e-05	0.00102	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.74e-05	0.00102	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYTB—ovarian cancer	3.68e-05	0.000998	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	3.63e-05	0.000985	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PPP1CC—ovarian cancer	3.55e-05	0.000965	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	3.48e-05	0.000944	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NME2—ovarian cancer	3.44e-05	0.000933	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.41e-05	0.000926	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	3.35e-05	0.00091	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	3.31e-05	0.000898	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	3.31e-05	0.000898	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPP1CC—ovarian cancer	3.29e-05	0.000893	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—BRIP1—ovarian cancer	3.29e-05	0.000893	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.23e-05	0.000877	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—BRIP1—ovarian cancer	3.21e-05	0.000873	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPP1CC—ovarian cancer	3.21e-05	0.000873	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—PIK3CA—ovarian cancer	3.21e-05	0.000871	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	3.12e-05	0.000848	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—MAPK1—ovarian cancer	3.08e-05	0.000837	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.05e-05	0.000828	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.92e-05	0.000792	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	2.87e-05	0.000779	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYTB—ovarian cancer	2.84e-05	0.000772	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.78e-05	0.000755	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.78e-05	0.000754	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HDAC6—ovarian cancer	2.69e-05	0.000731	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PPP2R1A—ovarian cancer	2.66e-05	0.000721	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	2.66e-05	0.000721	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NME2—ovarian cancer	2.65e-05	0.00072	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYTB—ovarian cancer	2.59e-05	0.000704	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCL8—ovarian cancer	2.55e-05	0.000693	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	2.54e-05	0.00069	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.53e-05	0.000688	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.49e-05	0.000675	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.49e-05	0.000675	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—HRAS—ovarian cancer	2.48e-05	0.000672	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—YAP1—ovarian cancer	2.38e-05	0.000647	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.38e-05	0.000645	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—XIAP—ovarian cancer	2.34e-05	0.000634	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SMARCA4—ovarian cancer	2.28e-05	0.000618	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BRIP1—ovarian cancer	2.27e-05	0.000615	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	2.27e-05	0.000615	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EREG—ovarian cancer	2.22e-05	0.000603	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYTB—ovarian cancer	2.22e-05	0.000601	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—YAP1—ovarian cancer	2.21e-05	0.000599	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.17e-05	0.000588	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—YAP1—ovarian cancer	2.16e-05	0.000585	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PGR—ovarian cancer	2.08e-05	0.000565	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CG—ovarian cancer	1.96e-05	0.000532	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.94e-05	0.000526	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.94e-05	0.000526	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PARP1—ovarian cancer	1.94e-05	0.000525	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6ST—ovarian cancer	1.85e-05	0.000502	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.81e-05	0.000492	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—FASN—ovarian cancer	1.8e-05	0.000488	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CG—ovarian cancer	1.78e-05	0.000483	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.77e-05	0.00048	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—FASN—ovarian cancer	1.76e-05	0.000477	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.73e-05	0.000469	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CD—ovarian cancer	1.72e-05	0.000467	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYTB—ovarian cancer	1.71e-05	0.000464	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.71e-05	0.000464	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.67e-05	0.000453	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—YAP1—ovarian cancer	1.67e-05	0.000452	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.65e-05	0.000448	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.65e-05	0.000448	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.64e-05	0.000445	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.6e-05	0.000435	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PPP2R1A—ovarian cancer	1.57e-05	0.000426	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CD—ovarian cancer	1.56e-05	0.000424	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—YAP1—ovarian cancer	1.52e-05	0.000413	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.5e-05	0.000408	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CB—ovarian cancer	1.5e-05	0.000407	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.49e-05	0.000406	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.49e-05	0.000406	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.45e-05	0.000394	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.45e-05	0.000394	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL8—ovarian cancer	1.44e-05	0.000391	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.42e-05	0.000385	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.41e-05	0.000383	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—ovarian cancer	1.38e-05	0.000374	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CB—ovarian cancer	1.36e-05	0.00037	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—FASN—ovarian cancer	1.36e-05	0.000369	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.35e-05	0.000366	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.34e-05	0.000363	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TYMS—ovarian cancer	1.32e-05	0.00036	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.32e-05	0.000359	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.32e-05	0.000358	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL8—ovarian cancer	1.31e-05	0.000355	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—YAP1—ovarian cancer	1.3e-05	0.000353	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TYMS—ovarian cancer	1.29e-05	0.000351	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.29e-05	0.00035	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.29e-05	0.000349	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.26e-05	0.000343	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—ovarian cancer	1.25e-05	0.00034	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TERT—ovarian cancer	1.25e-05	0.000338	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—FASN—ovarian cancer	1.24e-05	0.000336	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.24e-05	0.000336	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.22e-05	0.000331	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.18e-05	0.000319	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—ovarian cancer	1.15e-05	0.000313	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.15e-05	0.000313	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.13e-05	0.000307	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.13e-05	0.000306	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—ovarian cancer	1.11e-05	0.000302	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.1e-05	0.000298	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6ST—ovarian cancer	1.09e-05	0.000297	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.09e-05	0.000296	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—ovarian cancer	1.07e-05	0.00029	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FASN—ovarian cancer	1.06e-05	0.000287	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—ovarian cancer	1.05e-05	0.000285	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—ovarian cancer	1.05e-05	0.000285	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—NRAS—ovarian cancer	1.05e-05	0.000285	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—ovarian cancer	1.04e-05	0.000283	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.04e-05	0.000283	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.02e-05	0.000277	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—ovarian cancer	1.01e-05	0.000273	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.01e-05	0.000273	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—YAP1—ovarian cancer	1e-05	0.000272	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TYMS—ovarian cancer	1e-05	0.000272	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1e-05	0.000272	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.96e-06	0.00027	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.85e-06	0.000267	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—ovarian cancer	9.72e-06	0.000264	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1B1—ovarian cancer	9.64e-06	0.000262	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK1—ovarian cancer	9.57e-06	0.00026	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—ovarian cancer	9.57e-06	0.00026	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—ovarian cancer	9.5e-06	0.000258	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—ovarian cancer	9.29e-06	0.000252	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—ovarian cancer	9.24e-06	0.000251	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—ovarian cancer	9.15e-06	0.000248	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TYMS—ovarian cancer	9.13e-06	0.000248	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—ovarian cancer	9.04e-06	0.000245	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	8.55e-06	0.000232	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—ovarian cancer	8.55e-06	0.000232	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.51e-06	0.000231	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—ovarian cancer	8.35e-06	0.000227	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—ovarian cancer	8.31e-06	0.000225	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FASN—ovarian cancer	8.17e-06	0.000222	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—ovarian cancer	8.16e-06	0.000221	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—ovarian cancer	8.07e-06	0.000219	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—ovarian cancer	8.05e-06	0.000219	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—ovarian cancer	8.05e-06	0.000219	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	8.04e-06	0.000218	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—ovarian cancer	7.94e-06	0.000216	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TYMS—ovarian cancer	7.8e-06	0.000212	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.76e-06	0.000211	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—ovarian cancer	7.74e-06	0.00021	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.71e-06	0.000209	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HRAS—ovarian cancer	7.69e-06	0.000209	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—ovarian cancer	7.56e-06	0.000205	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—ovarian cancer	7.47e-06	0.000203	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—ovarian cancer	7.45e-06	0.000202	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.44e-06	0.000202	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—ovarian cancer	7.4e-06	0.000201	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—ovarian cancer	7.39e-06	0.000201	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—ovarian cancer	7.36e-06	0.0002	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—ovarian cancer	7.35e-06	0.0002	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—ovarian cancer	7.35e-06	0.000199	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—ovarian cancer	7.28e-06	0.000198	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—ovarian cancer	7.21e-06	0.000196	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—ovarian cancer	7.14e-06	0.000194	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.03e-06	0.000191	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—ovarian cancer	7e-06	0.00019	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—ovarian cancer	6.96e-06	0.000189	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—ovarian cancer	6.79e-06	0.000184	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	6.7e-06	0.000182	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.6e-06	0.000179	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—ovarian cancer	6.46e-06	0.000175	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—ovarian cancer	6.44e-06	0.000175	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—ovarian cancer	6.29e-06	0.000171	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—ovarian cancer	6.28e-06	0.000171	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	6.28e-06	0.000171	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	6.22e-06	0.000169	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	6.21e-06	0.000168	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.13e-06	0.000166	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TYMS—ovarian cancer	6.02e-06	0.000163	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6e-06	0.000163	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	5.94e-06	0.000161	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	5.89e-06	0.00016	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—ovarian cancer	5.78e-06	0.000157	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—ovarian cancer	5.72e-06	0.000155	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	5.66e-06	0.000154	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	5.65e-06	0.000153	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—ovarian cancer	5.63e-06	0.000153	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	5.34e-06	0.000145	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	5.13e-06	0.000139	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—ovarian cancer	5.03e-06	0.000137	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	4.91e-06	0.000133	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—ovarian cancer	4.86e-06	0.000132	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—ovarian cancer	4.85e-06	0.000132	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—ovarian cancer	4.75e-06	0.000129	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—ovarian cancer	4.54e-06	0.000123	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	4.54e-06	0.000123	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—ovarian cancer	4.44e-06	0.00012	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—ovarian cancer	4.44e-06	0.00012	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.42e-06	0.00012	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—ovarian cancer	4.39e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—ovarian cancer	4.35e-06	0.000118	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	4.01e-06	0.000109	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.88e-06	0.000105	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—ovarian cancer	3.79e-06	0.000103	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—ovarian cancer	3.71e-06	0.000101	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—ovarian cancer	3.63e-06	9.84e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—ovarian cancer	3.43e-06	9.31e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.39e-06	9.19e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.13e-06	8.49e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—ovarian cancer	2.93e-06	7.94e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—ovarian cancer	2.8e-06	7.61e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.67e-06	7.26e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—ovarian cancer	2.56e-06	6.94e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—ovarian cancer	2.18e-06	5.93e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.06e-06	5.6e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—ovarian cancer	1.69e-06	4.58e-05	CbGpPWpGaD
